Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Steven M Klosk is Director at Lisata Therapeutics. OQRO lists 1 transaction filed with the SEC under this name, the latest on Jan 13, 2026, each linked to the official Form 4.
Director
Disclosures on record
1
Companies involved
1
As of the latest filing on , Steven M Klosk reported holding 95,815 shares of Lisata Therapeutics (LSTA), worth about $116K at the last close of $1 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Lisata Therapeutics LSTA | 95,815 | 96K direct | $1 | $116K | Jan 9, 2026 |
Is this Steven M Klosk’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Steven M Klosk bought shares on the open market in 2014, and has not bought since 2014.
Steven M Klosk reported 1 open-market purchase and 0 sales since 2014; purchases in 2014.
| Year | Bought | Sold |
|---|---|---|
| 2014 | $40K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Jan 9, 202630Kdisclosed Jan 13
DetailsOfficial recordSteven M Klosk reported 1 open-market purchase and 0 sales here, 2014.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Jan 9, 2026, Steven M Klosk reported holding 95,815 shares of Lisata Therapeutics (LSTA). At the last close of $1 on Nov 13, 2026, that is about $116K. This is the stake disclosed in filings, not a net worth.
Steven M Klosk bought shares on the open market in 2014, and has not bought since 2014.
In SEC filings since 2014: the latest open-market purchase is from 2014; no open-market sale is on record.
Lisata Therapeutics (LSTA), from 2014 to 2014: 1 purchase and 0 sales.
